Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NANCHANG, China, Jan. 20, 2021 /Xinhua-AsiaNet/-- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).Preclinical studies of JMB2002 including pharmacology and toxicity ...
Authors: LATEST ASIANET NEWS RELEASES